Sheila Gujrathi, Director at Ventyx Biosciences, Inc. (VTYX), sold 200,000 shares at $33.73 ($6.7M) on 2023-03-30, disclosed to the SEC on 2023-03-31.
Open-market sale of $6.7M VTYX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.73 | 100,000 | $3.4M | 50.0% |
| 2 | $33.73 | 100,000 | $3.4M | 50.0% |
| Total | $33.73 avg | 200,000 | $6.7M | 100% |
| Filing → |
| RCPT | SELL | 2014-11-12 | $3.3M | — | Filing → |
| RCPT | SELL | 2014-09-24 | $1.8M | — | Filing → |